Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,467 | -8,294 | -8,589 | -8,107 | -8,822 |
| Depreciation Amortization | 744 | 759 | 748 | 723 | 723 |
| Accounts payable and accrued liabilities | 184 | 706 | 118 | 41 | -711 |
| Other Working Capital | 21 | 997 | 1,799 | 215 | -540 |
| Other Operating Activity | 40 | -483 | 254 | 1,237 | 1,137 |
| Operating Cash Flow | $-8,479 | $-6,316 | $-5,670 | $-5,891 | $-8,214 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -57 | -157 | -152 | -324 | -239 |
| Investing Cash Flow | $-57 | $-157 | $-152 | $-324 | $-239 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,296 | 3,120 | N/A | N/A | 16,564 |
| Other Financing Activity | 0 | 0 | -95 | -235 | -1,303 |
| Financing Cash Flow | $5,296 | $3,120 | $-95 | $-235 | $15,261 |
| Beginning Cash Position | 4,798 | 8,150 | 14,066 | 20,517 | 13,709 |
| End Cash Position | 1,559 | 4,798 | 8,150 | 14,066 | 20,517 |
| Net Cash Flow | $-3,239 | $-3,352 | $-5,917 | $-6,450 | $6,808 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,479 | -6,316 | -5,670 | -5,891 | -8,214 |
| Capital Expenditure | -57 | -157 | -152 | -324 | -239 |
| Free Cash Flow | -8,536 | -6,472 | -5,822 | -6,216 | -8,453 |